Novo Nordisk’s (NVO) blockbuster diabetes drug Ozempic may have a potential link with an eye condition that causes vision loss, according to a non-peer reviewed  study published Thursday on medRxiv.Read more...

Quartz

United States

Ozempic could be linked to a common cause of sudden blindness, another study finds

Health Secretary West Streeting warned ‘these are not cosmetic drugs… to help get a body beautiful picture for Instagram’ (Picture: Reuters / Getty)  The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a gamechanger with the potential to save millions of lives, and billions of pounds. Illnesses caused by obesity cost the NHS more than £11 billion per year, prompting the government an…

Ad Fontes Media

All Sides

Media Bias/Fact Check

Metro News

Alfred Harmsworth (barrister)

Geraldine Mary Harmsworth

Patricia Harmsworth, Viscountess Rothermere

London

Greater London

England

United Kingdom

Weight-loss drug Ozempic could increase risk of sight loss

Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that backs up Harvard University research published earlier this year.

The West Australian

Kerry Stokes

Australia

Ozempic link to rare vision loss risk confirmed in study

Toronto Sun

Leon Cooperman

Allianz

Toronto

Ontario

Canada

Diabetes patients using the drug face more than double the risk of developing NAION, a condition affecting the optic nerve

GB News

Ozempic linked to risk of rare irreversible vision loss after large-scale trial

Danish pharmaceutical company Novo Nordisk fell on the Copenhagen stock market on Friday after news about weight loss drug Ozempic. According to a new study, there is a link between Ozempic and an increased risk of a rare form of vision loss, Bloomberg news agency reported. The stock lost nearly 4 percent, the sharpest decline in about a month.

De Deense farmaceut Novo Nordisk ging vrijdag omlaag op de aandelenbeurs in Kopenhagen na nieuws over afslankmedicijn Ozempic. Volgens een nieuwe studie is er een verband tussen Ozempic en een verhoogd risico op een zeldzame vorm van verlies van gezichtsvermogen, meldde persbureau Bloomberg. Het aandeel verloor bijna 4 procent, de sterkste daling sinds ongeveer een maand.

Maker afslankmedicijn Ozempic omlaag op Deense beurs na studie

rd.nl

Apeldoorn

Gelderland

Netherlands

Ozempic slimming drug maker down on Danish stock market after study

The successful injection of Ozempic by Novo Nordisk A/S was linked to a higher risk of a rare form of vision loss in a study that supports a Harvard University research published earlier this year. Diabetic patients using Ozempic were more than twice as likely to be diagnosed with this rare disease, called NAION, than those who took another type of diabetes medicine, according to a team of researchers who studied years of patient records from De…

La exitosa inyección de Ozempic de Novo Nordisk A/S fue vinculada a un mayor riesgo de una rara forma de pérdida de visión en un estudio que respalda una investigación de la Universidad de Harvard publicada a principios de este año. Los pacientes diabéticos que utilizaron Ozempic tenían más del doble de probabilidades de ser diagnosticados con esta rara enfermedad, llamada NAION, que aquellos que tomaron otro tipo de medicamento para la diabetes…

Ozempic puede causar pérdida de visión: Esto dice el estudio sobre pacientes diabéticos

El Financiero

Mexico

Ozempic can cause vision loss: This is what the study on diabetic patients says.

Another study has been published suggesting that patients taking semaglutide—the active ingredient in Novo Nordisk’s blockbuster drug Ozempic—may face a higher risk of developing a rare eye condition that can lead to blindness.  “The glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide has quickly become a key treatment for managing type 2 diabetes and obesity. Recent findings […]

Zero Hedge

New Study Links Ozempic To Vision Loss, Confirms Harvard Research - Nemos News Network

Health Secretary West Streeting warned ‘these are not cosmetic drugs… to help get a body beautiful picture for Instagram’ (Picture: Reuters / Getty) The weight-loss drug Ozempic could increase the risk of vision loss, a new study found. Ozempic has been hailed as a gamechanger with the potential to save millions of lives, and billions of pounds. Illnesses caused by obesity cost the NHS more than £11 billion per year, prompting the government and…

Usa news site

A new study uncovers a shocking link between Ozempic and sudden blindness. Learn the potential risks, what the research says, and what you need to know to protect your vision.

Ozempic could be linked to a common cause of sudden blindness, another study finds

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics